We are live on
!
Find out more
HC
Henshaw Capital Portfolio holdings
AUM
$2.7B
1-Year Est. Return
29.67%
This Fund
S&P 500
This Quarter
Est. Return
+0.72%
1 Year Est. Return
+29.67%
3 Year Est. Return
+102.72%
5 Year Est. Return
+136.36%
10 Year Est. Return
+453.01%
AUM
$1.6B
AUM Growth
+$10.6M
(+0.67%)
Cap. Flow
+$7.56M
Cap. Flow
% of AUM
0.47%
Top 10 Holdings %
Top 10 Hldgs %
35.34%
Holding
364
New
15
Increased
80
Reduced
28
Closed
37
Top Buys
| 1 |
Applied Materials
AMAT
|
+$17.1M |
| 2 |
Pfizer
PFE
|
+$1.37M |
| 3 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$977K |
| 4 |
Aramark
ARMK
|
+$631K |
| 5 |
GoDaddy
GDDY
|
+$575K |
Top Sells
| 1 |
Alibaba
BABA
|
+$1.48M |
| 2 |
JD.com
JD
|
+$1.1M |
| 3 |
Fair Isaac
FICO
|
+$804K |
| 4 |
Infosys
INFY
|
+$771K |
| 5 |
SK Telecom
SKM
|
+$645K |
Sector Composition
| 1 | Technology | 25.5% |
| 2 | Industrials | 15.01% |
| 3 | Financials | 13.22% |
| 4 | Consumer Discretionary | 10.91% |
| 5 | Communication Services | 10.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Genmab
GMAB
$17.6B
| $227K | 0.01% |
5,204
| – | – |
|
302
Sprout Social
SPT
$510M
| $227K | 0.01% |
+1,858
| New | +$202K |
|
303
CRISPR Therapeutics
CRSP
$4.97B
| $226K | 0.01% |
2,022
+780
| +63% | +$98K |
|
304
MasTec
MTZ
$28.8B
| $226K | 0.01% |
2,618
| – | – |
|
305
Chevron
CVX
$362B
| $224K | 0.01% |
+2,211
| New | +$221K |
|
306
LXP Industrial Trust
LXP
$3.24B
| $221K | 0.01% |
3,466
| – | – |
|
|
MIME
307
DELISTED
Mimecast Limited
MIME
| $220K | 0.01% |
+3,454
| New | +$211K |
|
308
Agios Pharmaceuticals
AGIO
$2.37B
| $218K | 0.01% |
4,727
| – | – |
|
309
Pebblebrook Hotel Trust
PEB
$2.12B
| $218K | 0.01% |
+9,724
| New | +$215K |
|
310
AbbVie
ABBV
$432B
| $216K | 0.01% |
2,000
| – | – |
|
|
311
Alibaba
BABA
$269B
| $216K | 0.01% |
1,456
-8,132
| -85% | -$1.48M |
|
|
NP
312
DELISTED
Neenah, Inc. Common Stock
NP
| $215K | 0.01% |
4,619
| – | – |
|
313
Lloyds Banking Group
LYG
$86.2B
| $214K | 0.01% |
87,246
-91,213
| -51% | -$223K |
|
314
Artivion
AORT
$1.12B
| $210K | 0.01% |
9,426
| – | – |
|
|
NBIS
315
Nebius Group N.V.
NBIS
$49.3B
| $210K | 0.01% |
2,635
-6,429
| -71% | -$469K |
|
316
Baidu
BIDU
$37.3B
| $209K | 0.01% |
1,360
-636
| -32% | -$104K |
|
317
PTC Therapeutics
PTCT
$6.48B
| $206K | 0.01% |
5,538
| – | – |
|
318
Patterson-UTI
PTEN
$3.74B
| $206K | 0.01% |
22,876
+11,885
| +108% | +$96.2K |
|
319
L3Harris
LHX
$54B
| $205K | 0.01% |
931
| – | – |
|
320
Nexstar Media Group
NXST
$5.36B
| $204K | 0.01% |
+1,343
| New | +$198K |
|
321
City Holding Co
CHCO
$1.89B
| $204K | 0.01% |
+2,615
| New | +$199K |
|
322
Black Hills Corp
BKH
$5.75B
| $204K | 0.01% |
3,243
| – | – |
|
|
RPT
323
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $190K | 0.01% |
14,862
| – | – |
|
324
Vale
VALE
$62.1B
| $189K | 0.01% |
13,532
-17,910
| -57% | -$351K |
|
325
BrightView Holdings
BV
$1.34B
| $163K | 0.01% |
11,046
| – | – |
|
Similar funds
TPSF
CI
GIA
PCM
SFS
HCM
NB
WGI